LigoCyte Pharmaceuticals
A company that develops vaccines and monoclonal antibodies to treat gastrointestinal and respiratory conditions
1
Funding Rounds
$28.0m
Money raised
Overview
A company that develops vaccines and monoclonal antibodies to treat gastrointestinal and respiratory conditions
- Website:
Funding series
Funding Series Analysis
The company LigoCyte Pharmaceuticals has raised a total of $28m in funding over 1 rounds.
Key Insights:
- LigoCyte Pharmaceuticals Series B round: $28m
LigoCyte Pharmaceuticals Series B round
$28m
Industries
LigoCyte Pharmaceuticals is active in the following industries: